• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Bruno Buecher, Wulfran Cacheux, Etienne Rouleau, Barbara Dieumegard, Emmanuel Mitry, Astrid Lièvre
  • Medicine
  • Digestive and liver disease : official journal of…
  • 2013 (First Publication: 1 June 2013)
  • Microsatellite instability is the consequence of a deficient mismatch repair system. It has a key role in the diagnostic strategy of Lynch syndrome, where tumours are all characterized by theContinue Reading
  • Romain Coriat, Olivier Mir, +6 authors François Goldwasser
  • Medicine
  • Investigational New Drugs
  • 2010 (First Publication: 1 February 2012)
  • SummaryPurpose The only drug that improves survival in hepatocellular carcinoma is sorafenib. FOLFOX-4 regimen is safe and widely used in patients with colorectal cancer, yielding interesting resultsContinue Reading
  • Sarah Leblanc, Célia Lloret Linares, Wulfran Cacheux, Luc Mouthon, Stanislas Chaussade
  • Medicine
  • Inflammatory bowel diseases
  • 2011 (First Publication: 1 March 2011)
  • To the Editor: Tumor necrosis factor-alpha (TNF-a) blockers are being increasingly used in the treatment of severe, active Crohn’s disease (CD). Adalimumab, a fully human TNF antagonist, is indicatedContinue Reading
  • Fady Daniel, Philippe Seksik, Wulfran Cacheux, Raymond Jian, Philippe Marteau
  • Medicine
  • Inflammatory bowel diseases
  • 2004 (First Publication: 1 May 2004)
  • Derivatives of 5-aminosalicylic acid (5-ASA) used for the treatment of inflammatory bowel disease may induce acute pancreatitis of immunoallergic origin. 4-aminosalicylic acid (4-ASA) differs fromContinue Reading
  • Eugenio Fernández, Wulfran Cacheux, +6 authors Arnaud Roth
  • Medicine
  • Digestive and liver disease : official journal of…
  • 2017 (First Publication: 1 May 2017)
  • BACKGROUND Perioperative chemotherapy improves the prognosis of patients with locoregionally advanced resectable gastric and gastro-esophageal junction adenocarcinoma. Nevertheless, only 50% ofContinue Reading